Verition Fund Management
WGS icon

Verition Fund Management’s GeneDx Holdings WGS Stock Holding History

Verition Fund Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,228
Closed -$290K – 3635
2025
Q4 		$290K Sell
2,228
-11,907
-84% -$1.63M ﹤0.01% 3020
2025
Q3 		$1.52M Buy
14,135
+2,840
+25% +$309K 0.01% 2201
2025
Q2 		$1.04M Sell
11,295
-10,113
-47% -$794K ﹤0.01% 2441
2025
Q1 		$1.9M Sell
21,408
-5,368
-20% -$466K 0.01% 1616
2024
Q4 		$2.06M Buy
26,776
+931
+4% +$65K 0.01% 1533
2024
Q3 		$1.1M Buy
25,845
+2,945
+13% +$99.5K 0.01% 1826
2024
Q2 		$599K Buy
+22,900
New +$434K ﹤0.01% 1957
2022
Q4 		– Sell
-403
Closed -$12K – 2808
2022
Q3 		$12K Hold
403
– – ﹤0.01% 2851
2022
Q2 		$17K Buy
+403
New +$27.3K ﹤0.01% 2228

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Verition Fund Management's WGS Position: Q1 2026 in Review

Verition Fund Management sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 2,228 shares — an estimated $290K sold.

Verition Fund Management first reported a position in WGS in Q2 2022 and held it in 9 quarters. The position peaked at $2.06M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Verition Fund Management reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 2,228 GeneDx Holdings shares in Q1 2026, an estimated $290K.
  • Verition Fund Management first reported a position in GeneDx Holdings in Q2 2022 and held it in 9 quarters.
  • Verition Fund Management's GeneDx Holdings position peaked at $2.06M in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.